Table 1 Immunohistochemical expression of Chk2 and clinicopathological parameters evaluated in this study
From: Immunohistochemistry analysis of checkpoint kinase 2 in oral squamous cell carcinoma
Feature | No (%) of patients (N = 101) | |
|---|---|---|
Chk2 | High expression | 58 (57.43%) |
Low expression | 43 (42.57%) | |
Sex | Male | 88 (87.13%) |
Female | 13 (12.87%) | |
Age | < 40 | 03 (2.97%) |
41–60 | 49 (48.5%) | |
> 60 | 49 (48.51%) | |
Smoking | Yes | 81 (80.20%) |
No | 18 (17.82%) | |
No information | 02 (1.98%) | |
Alcohol consumption | Yes | 78 (77.23%) |
No | 21 (20.79%) | |
No information | 02 (1.98%) | |
Staging | ECI | 04 (3.96%) |
ECII | 11 (10.89%) | |
ECIII | 14 (13.86%) | |
ECIV | 33 (32.67%) | |
In situ | 01 (0.99%) | |
No information | 38 (37.62%) | |
Tumor size | T1 | 05 (5.00%) |
T2 | 21 (20.79%) | |
T3 | 11 (10.89%) | |
T4 | 26 (25.74%) | |
No information | 37 (36.63%) | |
In situ | 01 (0.99%) | |
Regional metastasis | Yes | 40 (39.60%) |
No | 61 (60.40%) | |
Distant metastasis | Yes | 16 (15.84%) |
No | 85 (84.16%) | |
Tumor histological grade | Well | 27 (26.73%) |
Moderate | 63 (62.38%) | |
Poor | 10 (9.90%) | |
No information | 01 (0.99%) | |
Relapse | Yes | 43 (42.57%) |
No | 56 (55.45%) | |
No information | 02 (1.98%) | |
Death | Yes | 57 (56.44%) |
No | 45 (43.56%) |